Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glial cell line–derived neurotrophic factor (GDNF) pathway is a critical signaling system involved in the survival, development, and function of various neuronal populations. GDNF is a small, highly conserved protein that belongs to the transforming growth factor-β (TGF-β) superfamily and exerts potent neuroprotective effects. It is widely distributed throughout both the central and peripheral nervous systems and can be secreted by astrocytes, oligodendrocytes, Schwann cells, motor neurons, and skeletal muscle. The pathway involves the ligand GDNF, the co-receptor GFRα1, and the tyrosine kinase receptor RET. Activation of RET triggers downstream signaling cascades essential for neuronal survival and differentiation. Dysregulation of the GDNF pathway is implicated in various diseases, including Parkinson's disease, Hirschsprung's disease, neuropathic pain, liver fibrosis and some cancers, making it a target for therapeutic intervention.
GDNF binds to GFRα1, leading to RET receptor activation and downstream signaling cascades including MAPK/ERK.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glial Cell Line-Derived Neurotrophic Factor Pathway (GDNF Pathway).